Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin.
| dc.authorid | DEMIR, Mehmet/0000-0001-5942-3751 | |
| dc.authorwosid | DEMIR, Mehmet/AAH-2121-2019 | |
| dc.contributor.author | Tobu, M | |
| dc.contributor.author | Hoppensteadt, DA | |
| dc.contributor.author | Chatha, M | |
| dc.contributor.author | Bansal, V | |
| dc.contributor.author | Moghaddam, M | |
| dc.contributor.author | Sarfraz, A | |
| dc.contributor.author | Demir, M | |
| dc.date.accessioned | 2024-06-12T11:23:51Z | |
| dc.date.available | 2024-06-12T11:23:51Z | |
| dc.date.issued | 2003 | |
| dc.department | Trakya Üniversitesi | en_US |
| dc.description | 45th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2003 -- SAN DIEGO, CALIFORNIA | en_US |
| dc.description.abstract | [Abstract Not Available] | en_US |
| dc.description.sponsorship | Amer Soc Hematol | en_US |
| dc.identifier.endpage | 119B | en_US |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issue | 11 | en_US |
| dc.identifier.startpage | 119B | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.14551/26685 | |
| dc.identifier.volume | 102 | en_US |
| dc.identifier.wos | WOS:000186537100478 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Amer Soc Hematology | en_US |
| dc.relation.ispartof | Blood | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | [No Keywords] | en_US |
| dc.title | Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin. | en_US |
| dc.type | Conference Object | en_US |
